Gainers
Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share agreement with Google LLC to develop its enterprise tech platform and software products.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Alpine Immune Sciences (NASDAQ:ALPN) brought in sales totaling $7.19 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 2.31%, resulting in a loss of $10.73 million.
Shares of Alpine Immune Sciences (NASDAQ:ALPN) moved higher in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share rose 13.21% year over year to ($0.46), which missed the estimate of ($0.40).
Alpine Immune Sciences (NASDAQ:ALPN) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.40) by 15 percent. This is a 13.21 percent increase over losses of $(0.53) per share